A Phase Ib Dose Escalation Trial of Carfilzomib in Combination With Bendamustine and Rituximab In Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2017
At a glance
- Drugs Carfilzomib (Primary) ; Bendamustine; Rituximab
- Indications Non-Hodgkin's lymphoma
- Focus Adverse reactions
- 07 Jun 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2019.
- 07 Jun 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2018.
- 08 Mar 2015 Planned End Date changed from 1 Dec 2016 to 1 Jun 2017 as reported by ClinicalTrials.gov record.